Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice
Circulation: Cardiovascular Interventions · 2023-09 · 16 (9)
DOI: 10.1161/circinterventions.122.012805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2023-09. Verfasst von Jesse A Columbo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Vascular Surgery, Heart and Vascular Center (J.A.C., D.H.S., P.P.G.), Dartmouth-Hitchcock Medical Center, Lebanon, NH. Hauptthemen laut MEDLINE: Carotid Stenosis, Stroke. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: In 2015, the FDA approved transcarotid artery revascularization (TCAR) as an alternative to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF-CAS) for high-risk patients with carotid stenosis. This was granted in the absence of level 1 evidence to support TCAR. We aimed to document trends in TCAR utilization, its diffusion over time, and the clinical phenotypes of patients undergoing TCAR, CEA, and TF-CAS. METHODS: We used the Vascular Quality Initiative to study patients who underwent TCAR. We calculated the number of TCARs performed and the percent of TCAR utilization versus CEA/TF-CAS. Using data from before TCAR was widespread, we calculated propensity scores for patients to receive CEA. We applied this model to patients undergoing carotid revascularization from 2016 to 2022 and grouped patients by the procedure they ultimately underwent, examining overlap in score distribution to measure patient similarity. We measured the trend of in-hospital stroke/death after TCAR. RESULTS: We studied 31 447 patients who underwent TCAR from January 1, 2016 to March 31, 2022. The number of centers performing TCAR increased from 29 to 606. In 2021, TCAR represented 22.5% of carotid revascularizations at centers offering all 3 procedures. The percentage of patients that underwent TCAR who met approved high-risk criteria decreased from 88.5% to 80.9% ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Vascular Surgery, Heart and Vascular Center (J.A.C., D.H.S., P.P.G.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
- Geisel School of Medicine at Dartmouth College, Hanover, NH (J.A.C., D.H.S., P.P.G., A.J.O.).
- Department of Anesthesia (P.M.-C.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
- Department of Biomedical Data Science, Dartmouth College, Hanover, NH (P.M.-C., A.J.O.).
ORCID-Profile: Jesse A Columbo, Pablo Martinez-Camblor, Philip P Goodney, A James O'Malley
Förderung
- NHLBI NIH HHS
Zitieren
APA
Columbo, J. A., Stone, D. H., Martinez-Camblor, P., Goodney, P. P., & O'Malley, A. J. (2023). Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice. Circulation: Cardiovascular Interventions, 16(9). https://doi.org/10.1161/circinterventions.122.012805
Vancouver
Columbo JA, Stone DH, Martinez-Camblor P, Goodney PP, O'Malley AJ. Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice. Circulation: Cardiovascular Interventions. 2023;16(9). doi:10.1161/circinterventions.122.012805
BibTeX
@article{Columbo2023,
author = {Columbo, Jesse A and Stone, David H and Martinez-Camblor, Pablo and Goodney, Philip P and O'Malley, A James},
title = {Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice},
journal = {Circulation: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {9},
doi = {10.1161/circinterventions.122.012805}
}
EUVIMED